{
    "2021-11-15": [
        [
            {
                "time": "2021-11-15",
                "original_text": "Victim Fund Director Feinberg Is Named Mediator for J&J Fight",
                "features": {
                    "keywords": [
                        "Feinberg",
                        "Mediator",
                        "J&J"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters",
                "features": {
                    "keywords": [
                        "McKesson",
                        "Cardinal Health",
                        "AmerisourceBergen",
                        "Opioid",
                        "Trial"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Vaccines sent to some of the 'hardest to reach' places with Zipline drone delivery",
                "features": {
                    "keywords": [
                        "Vaccines",
                        "Zipline",
                        "Drone",
                        "Delivery"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "UPDATE 4-Washington state, in $95 billion opioid trial, blames drug distributors for crisis",
                "features": {
                    "keywords": [
                        "Washington",
                        "Opioid",
                        "Trial",
                        "Drug Distributors"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "J&J (JNJ) to Separate Consumer Unit Into New Company, Stock Up",
                "features": {
                    "keywords": [
                        "J&J",
                        "Separate",
                        "Consumer",
                        "Unit",
                        "Stock Up"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Should You Buy Johnson & Johnson Before It Splits?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Split",
                        "Buy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "10 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Mark Lampert",
                        "Biotechnology Value Fund"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "McKesson, drug distributors face $95 billion opioid trial in Washington state",
                "features": {
                    "keywords": [
                        "McKesson",
                        "Drug Distributors",
                        "Opioid",
                        "Trial"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Washington state seeks over $38 billion from opioid distributors",
                "features": {
                    "keywords": [
                        "Washington",
                        "Opioid",
                        "Distributors"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Will Johnson & Johnson’s Split Pay Off? History Says No.",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Split",
                        "History"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Johnson & Johnson Spinoff Plans Point to Rise of Direct to Consumer Commerce",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Spinoff",
                        "Direct to Consumer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}